Showing results (2201-2210 of 5,261) with videos related to

Sort By:
Pageof 527
Oncology|April 8, 2025
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and AlbuminRossella Donghia, Brian Irving Carr, Sezai Yilmaz
Oncology|September 25, 2025
Differences in Safety Signal Detection between Osimertinib and First- and Second-Generation EGFR-TKIs: A Pharmacovigilance Study Using a Spontaneous Reporting SystemTomoya Sugimoto, Yoshihiro Noguchi, Rikuto Masuda, et al.
Oncology|August 15, 2025
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapyFrancesco Vitiello, Caterina Vivaldi, Mario Domenico Rizzato, et al.
Oncology|January 1, 1986
Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinomaM Tatsuta, H Yamamura, H Iishi, et al.
Oncology|January 1, 1989
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusionH W Bruckner, J Kalman, M Spigelman, et al.
Oncology|January 19, 2013
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma modelXimena Camacho, María Fernanda García, Victoria Calzada, et al.
Oncology|May 22, 2013
In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progressionJiro Shimazaki, Yoshihisa Goto, Kiyotaka Nishida, et al.
Oncology|January 1, 1990
Clinical staging of adult non-Hodgkin's lymphomaN Lalitha
Oncology|April 26, 2013
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90Wan-Yee Lau, Bruno Sangro, Pier-Jer Chen, et al.
Oncology|April 19, 2013
S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinomaYasunori Akutsu, Tsuguaki Kono, Masaya Uesato, et al.
Pageof 527